IL-9+ IL-10+ T cells link immediate allergic response to late phase reaction

Clinical and Experimental Immunology

Volumn 165, Issue 1, 2011, Pages 29-37

  He, S H ^a   Liu, Z Q ^b   Chen, X ^b   Song, C H ^b   Zhou, L F ^a   Ma, W J ^a   Cheng, L ^b   Du, Y ^b   Tang, S G ^b   Yang, P C ^b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Food allergy; Intestine; Late phase reaction; T helper cell

Indexed keywords

ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 2; MACROPHAGE INFLAMMATORY PROTEIN ANTIBODY; PROTEIN ANTIBODY; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INHIBITION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; INTESTINE; JEJUNUM; LATE PHASE ALLERGIC REACTION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH2 CELL;

ANIMALS; ANTIBODIES, BLOCKING; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL3; DISEASE MODELS, ANIMAL; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNIZATION; INTERLEUKIN-10; INTERLEUKIN-9; JEJUNUM; MACROPHAGES; MICE; NEUTROPHILS; T-LYMPHOCYTES;

EID: 79958179409     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04394.x     Document Type: Article

References (21)

1. Sicherer SH, Leung DY. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2009. J Allergy Clin Immunol 2010; 125:85-97.
2. Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005; 307:1920-5.
3. Verstraelen S, Bloemen K, Nelissen I, Witters H, Schoeters G, Van Den Heuvel R. Cell types involved in allergic asthma and their use in in vitro models to assess respiratory sensitization. Toxicol In Vitro 2008; 22:1419-31.
4. Elias JA. Airway remodeling in asthma. Unanswered questions. Am J Respir Crit Care Med 2000; 161:S168-71.
5. Forbes EE, Groschwitz K, Abonia JP etal. IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med 2008; 205:897-913.
6. Hauber HP, Bergeron C, Hamid Q. IL-9 in allergic inflammation. Int Arch Allergy Immunol 2004; 134:79-87.
7. Wang TN, Chen WY, Huang YF etal. The synergistic effects of the IL-9 gene and environmental exposures on asthmatic Taiwanese families as determined by the transmission/disequilibrium test. Int J Immunogenet 2006; 33:105-10.
8. Hu ZQ, Zhao WH, Shimamura T. Regulation of mast cell development by inflammatory factors. Curr Med Chem 2007; 14:3044-50.
9. Dardalhon V, Awasthi A, Kwon H etal. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 2008; 9:1347-55.
10. Yang PC, Xing Z, Berin CM etal. TIM-4 expressed by mucosal dendritic cells plays a critical role in food antigen-specific Th2 differentiation and intestinal allergy. Gastroenterology 2007; 133:1522-33.
11. Ajuebor MN, Kunkel SL, Hogaboam CM. The role of CCL3/macrophage inflammatory protein-1alpha in experimental colitis. Eur J Pharmacol 2004; 497:343-9.
12. Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2010; 125:S73-80.
13. Charlesworth EN, Hood AF, Soter NA, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest 1989; 83:1519-26.
14. Yang PC, Berin MC, Yu L, Perdue MH. Mucosal pathophysiology and inflammatory changes in the late phase of the intestinal allergic reaction in the rat. Am J Pathol 2001; 158:681-90.
15. Kato M, Yamada Y, Maruyama K, Hayashi Y. Serum eosinophil cationic protein and 27 cytokines/chemokines in acute exacerbation of childhood asthma. Int Arch Allergy Immunol 2010; 152 (Suppl. 1):62-6.
16. Hatano Y, Katagiri K, Takayasu S. Increased levels in vivo of mRNAs for IL-8 and macrophage inflammatory protein-1 alpha (MIP-1 alpha), but not of RANTES mRNA in peripheral blood mononuclear cells of patients with atopic dermatitis (AD). Clin Exp Immunol 1999; 117:237-43.
17. Ritz SA, Cundall MJ, Gajewska BU etal. The lung cytokine microenvironment influences molecular events in the lymph nodes during Th1 and Th2 respiratory mucosal sensitization to antigen in vivo. Clin Exp Immunol 2004; 138:213-20.
18. Rytkönen J, Karttunen TJ, Karttunen R, Valkonen KH, Björkstén B, Kokkonen J. BCG vaccine modulates intestinal and systemic response to beta-lactoglobulin. Pediatr Allergy Immunol 2004; 15:408-14.
19. Yang PC, Jury J, Söderholm JD, Sherman PM, McKay DM, Perdue MH. Chronic psychological stress in rats induces intestinal sensitization to luminal antigens. Am J Pathol 2006; 168:104-14.
20. Wang Q, Li H, Yao Y, Xia D, Zhou J. The overexpression of heparin-binding epidermal growth factor is responsible for Th17-induced airway remodeling in an experimental asthma model. J Immunol 2010; 185:834-41.
21. Matsui K, Nishikawa A. Lipoteichoic acid from Staphylococcus aureus induces Th2-prone dermatitis in mice sensitized percutaneously with an allergen. Clin Exp Allergy 2002; 32:783-8.